胃饲乙醇预处理诱导增强肝脏对缺血—再灌流的耐受性

结题报告
项目介绍
AI项目解读

基本信息

  • 批准号:
    39970727
  • 项目类别:
    面上项目
  • 资助金额:
    14.0万
  • 负责人:
  • 依托单位:
  • 学科分类:
    H0311.肝保护和人工肝
  • 结题年份:
    2002
  • 批准年份:
    1999
  • 项目状态:
    已结题
  • 起止时间:
    2000-01-01 至2002-12-31

项目摘要

Hepatic ischemia/reperfusion injury is a common problem encountered in many clinical conditions . It affects directly on the outcome of the patients. Although many studies have been done in this field, it still remains an unsolved problem..More and more evidence indicate that preconditioning, such as ischemia and heat shock, could protect liver against I/R injuries. But these methods are less likely to be applied in clinic because of their extensive damages to the body. So it is necessary to find out a new way of preconditioning on the liver..It is shown that heat shock protein 70s can be induced in several tissues and organs by low dose of ethanol exposure which lead will lead to more protective effect from cell injuries. In addition, ethanol preconditioning(EPC) is more convenient and acceptable for clinical use. Ethanol exposure can take effect in many ways for preconditioning, such as ischemia, endotoxin preconditioning. It is thought to elicit several preconditioning-like protection of the liver.Based on these investigations, this study aims to explore the induction of ischemia/reperfusion bearance of the rat liver by ethanol preconditioning and the related mechanisms.Methods and Results.1. Establishment of the ethanol-preconditioning protocol.Hepatic inflow occlusion under portal vein blood bypass mode was adopted in this study. Adult male Wistar rats were randomly divided into:normal control group(N); ethanol group(E):gastric gavage with a single dose of 40%,5 g/kg; ischemia-reperfusion group(IR):rats were subjected to ischemia for 90 min; and ethanol preconditioning group(EPC):rats were subjected to hepatic ischemia prior to a single dose of 40%,5 g/kg.bw of ethanol for 90 min . The mortality, pathological changes of the liver, activities of serum ALT and AST, were determined. Furthermore, based on the alcohol concentration, dose, chance of ethanol gavage, L27(313)orthogonal experiment was designed to optimize the protocol of ethanol preconditioning. Results ⑴ A slight symptom was observed in the rat after ethanol gavage. No rats died in the experiment. ⑵ No significant difference of ALT was observed between ethanol group and normal group; Compared with nomal control group, ALT in IR group and EPC group were significantly increased after reperfusion and reached their peak levels at 6 h and 3 h respectively. Compared with EPC group, ALT in IR group increased much higher at 6、12、24 h after reperfusion, but there was no significant differece between the two groups. ⑶ The alterations of the serum AST activity were similar to the ALT. But compared with IR group, AST in EPC group was elevated to a less degree during the liver reperfusion. ⑷In the E group, a normal liver structure was remained, only few inflammatory cells and some denaturalized hepatocytes around centrolobular veins were found. Except for many inflamatory cells and a few necrotic heptocytes around centrolobular veins, no other abnormality was found in EPC group during the reperfusion; A severity of liver damage was observed in IR group.⑸ Under the condition of 40%, 5 g/kg, 24 h prior to ischemia, a less pathological damage, less ALT leakage and high concentration of liver ATP, GSH reservation were observed..2. Study on the protective effect of the ethanol preconditioning against hepatic ischemia/reperfusion injuries .The optimized ethanol preconditioning protocol was adopted to investigate its protection against 90 min I/R liver injuries. Adult male Wistar rats were randomly divided into six groups: the normal control group; 0.9%NS group (NS); ethanol group (E); ischemia/reperfusion group(IR); 0.9%NS preconditioning combined with IR group(NPC);ethanol preconditioning combined with IR group(EPC).The mortalities of the rats were observed and serum ALT,AST activity, pathological changes of the liver, apoptic hepatocytes and liver GSH content were measured during the different phases of liver reperfusion. Results: ⑴ No death was found in each group; after 24 h reperfusion, the rats in EPC group recovered completely with a good c
基于生物应激保护原理,以预先胃饲乙醇对实验动物进行预处理,观测和分析其对继后的肝脏缺血—再灌流损害和耐受热缺血安全时限的影响及其与肝细胞hsp70s表达水平的关系,验证此种应激预处理能否增强宿主肝脏对缺血—再灌流的耐受性,为临床上预防肝脏缺血—再灌流损害提供新的途径和方法。

结项摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi || "--"}}
  • 发表时间:
    {{ item.publish_year || "--" }}
  • 期刊:
    {{ item.journal_name }}
  • 影响因子:
    {{ item.factor || "--"}}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.authors }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.authors }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.authors }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.authors }}

数据更新时间:{{ patent.updateTime }}

其他文献

肝受体显像剂~(99)Tc~m-HYNIC-NGA的制备与初步评价
  • DOI:
    --
  • 发表时间:
    --
  • 期刊:
    同位素
  • 影响因子:
    --
  • 作者:
    项灿宏;董家鸿;杨文江;王伟平;张现忠;庞燕
  • 通讯作者:
    庞燕
β-catenin在肝细胞癌中表达及其临床意义
  • DOI:
    --
  • 发表时间:
    --
  • 期刊:
    解放军医学杂志
  • 影响因子:
    --
  • 作者:
    别平;王曙光;吕文平;董家鸿;石爽;黄志强
  • 通讯作者:
    黄志强
实施快速手术住院制度 降低平均住院日
  • DOI:
    --
  • 发表时间:
    --
  • 期刊:
    中国医院管理
  • 影响因子:
    --
  • 作者:
    贺涛;张思兵;郭强;刘博;董家鸿
  • 通讯作者:
    董家鸿
HBV相关性肝细胞癌抑癌基因高甲基化现象及其机制的研究进展
  • DOI:
    --
  • 发表时间:
    --
  • 期刊:
    中国肿瘤临床
  • 影响因子:
    --
  • 作者:
    董家鸿;吕文平;高彬
  • 通讯作者:
    高彬
肝细胞癌中HBx蛋白表达对间歇肝门血流阻断技术肝切除预后的影响
  • DOI:
    --
  • 发表时间:
    2012
  • 期刊:
    中华普外科手术学杂志(电子版)
  • 影响因子:
    --
  • 作者:
    周开伦;苏明;千年松;董家鸿
  • 通讯作者:
    董家鸿

其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi || "--" }}
  • 发表时间:
    {{ item.publish_year || "--"}}
  • 期刊:
    {{ item.journal_name }}
  • 影响因子:
    {{ item.factor || "--" }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}
empty
内容获取失败,请点击重试
重试联系客服
title开始分析
查看分析示例
此项目为已结题,我已根据课题信息分析并撰写以下内容,帮您拓宽课题思路:

AI项目思路

AI技术路线图

董家鸿的其他基金

移植肝“毒性胆汁”形成及导致胆管损伤的分子机制
  • 批准号:
    30571834
  • 批准年份:
    2005
  • 资助金额:
    26.0 万元
  • 项目类别:
    面上项目
肝癌肝移植病人微转移与术后复发的关系
  • 批准号:
    30271285
  • 批准年份:
    2002
  • 资助金额:
    7.0 万元
  • 项目类别:
    面上项目

相似国自然基金

{{ item.name }}
  • 批准号:
    {{ item.ratify_no }}
  • 批准年份:
    {{ item.approval_year }}
  • 资助金额:
    {{ item.support_num }}
  • 项目类别:
    {{ item.project_type }}

相似海外基金

{{ item.name }}
{{ item.translate_name }}
  • 批准号:
    {{ item.ratify_no }}
  • 财政年份:
    {{ item.approval_year }}
  • 资助金额:
    {{ item.support_num }}
  • 项目类别:
    {{ item.project_type }}
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了

AI项目解读示例

课题项目:调控A型流感病毒诱导IFN-β表达的机制研究

AI项目摘要:

本研究聚焦于TRIM2蛋白在A型流感病毒诱导的IFN-β表达中的调控机制。A型流感病毒是全球性健康问题,其感染可导致严重的呼吸道疾病。IFN-β作为关键的抗病毒因子,其表达水平对抗病毒防御至关重要。然而,TRIM2如何调控IFN-β的表达尚未明确。本研究假设TRIM2通过与病毒RNA或宿主因子相互作用,影响IFN-β的产生。我们将采用分子生物学、细胞生物学和免疫学方法,探索TRIM2与A型流感病毒诱导IFN-β表达的关系。预期结果将揭示TRIM2在抗病毒免疫反应中的作用,为开发新的抗病毒策略提供理论基础。该研究对理解宿主抗病毒机制具有重要科学意义,并可能对临床治疗流感病毒感染提供新的视角。

AI项目思路:

科学问题:TRIM2如何调控A型流感病毒诱导的IFN-β表达?
前期研究:已有研究表明TRIM2参与抗病毒反应,但其具体机制尚不明确。
研究创新点:本研究将深入探讨TRIM2在IFN-β表达中的直接作用机制。
技术路线:包括病毒学、分子生物学、细胞培养和免疫检测技术。
关键技术:TRIM2与病毒RNA的相互作用分析,IFN-β启动子活性检测。
实验模型:使用A型流感病毒感染的细胞模型进行研究。

AI技术路线图

        graph TD
          A[研究起始] --> B[文献回顾与假设提出]
          B --> C[实验设计与方法学准备]
          C --> D[A型流感病毒感染模型建立]
          D --> E[TRIM2与病毒RNA相互作用分析]
          E --> F[TRIM2对IFN-β启动子活性的影响]
          F --> G[IFN-β表达水平测定]
          G --> H[TRIM2功能丧失与获得研究]
          H --> I[数据收集与分析]
          I --> J[结果解释与科学验证]
          J --> K[研究结论与未来方向]
          K --> L[研究结束]
      
关闭
close
客服二维码